Closed

HAV & B19 Testing Services

NHS Blood and Transplant · £6,100,000 · closes 22 Aug 2023

£6,100,000

Estimated value

Closed

Deadline

12 Jul 2023

Published

This tender has closed.

See what's open in architecture and engineering services, or get contracts like this in your inbox each morning — free.

Set up free alertsOpen architecture and engineering services tenders

About this contract

This Contract notice is a call for competition and is separate to any tender opportunity. Its purpose is to inform the market of a tender opportunity. NHS Blood and Transplant are looking for a fully integrated high throughput testing solution for the detection of hepatitis A virus (HAV) RNA and Parvovirus B19 DNA in partnership with NHSBT. Additionally, the solution must also be able to test for HBV DNA, HIV-1 RNA, HIV-2 RNA, HCV RNA, HEV RNA as contingency during a business continuity need for NHSBTs . The solution must have the relevant UKCA marking to support this ability. Participation is subject to the Supplier currently participating in the NHSBT KEG process, or confirmation that their testing solution has previously been KEG approved to deliver HAV & B19 Screening Services in partnership with NHSBT. All correspondence to: tennille.madigan@nhsbt.nhs.uk Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk

Key dates

Published12 Jul 2023
Submission deadline22 Aug 2023 Add to calendar ↓

Source

Tender documents portalOpen ↗
Source notice on Contracts FinderView ↗

Who to contact

NameTennille Madigan
Phone+447795483583

Tender documents

tenderNoticeOpen ↗

Similar open tenders

Contains public sector information licensed under OGL v3.0